2015 Vol.33, N°4 - Suppl.91 - Table of contents
Scleroderma 2015
Guest Editor: S. Bombardieri
One year in review
CER8791
2015,33,4,Suppl.91
Pg. 0003-0014
Free to view
Systemic sclerosis: a critical digest of the recent literature
S. Barsotti, C. Stagnaro, A. Della Rossa
S. Barsotti, C. Stagnaro, A. Della Rossa
Aetiopathogenesis
CER8157
2015,33,4,Suppl.91
Pg. 0015-0022
Free to view
Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model
Ö.N. Pamuk, G. Can, S. Ayvaz, T. Karaca, G.E. Pamuk, S. Demirtas, G.C. Tsokos
Ö.N. Pamuk, G. Can, S. Ayvaz, T. Karaca, G.E. Pamuk, S. Demirtas, G.C. Tsokos
Clinical aspects
CER7906
2015,33,4,Suppl.91
Pg. 0023-0025
Free to view
Prospective evaluation of frequency of signs of systemic sclerosis in 76 patients with morphea
D. Lipsker, D. Bessis, A. Cosnes, N. Kluger, V. Lutz, E. Sauleau, C. Francès
D. Lipsker, D. Bessis, A. Cosnes, N. Kluger, V. Lutz, E. Sauleau, C. Francès
CER7392
2015,33,4,Suppl.91
Pg. 0026-0030
Free to view
Factors influencing the occupational trajectory of patients with systemic sclerosis: a qualitative study
S. Decuman, V. Smith, M. Grypdonck, F. De Keyser, S. Verhaeghe
S. Decuman, V. Smith, M. Grypdonck, F. De Keyser, S. Verhaeghe
CER8166
2015,33,4,Suppl.91
Pg. 0031-0035
Free to view
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
E. Ochoa, J.-E. Martin, S. Assasi, L. Beretta, P. Carreira, A. Guillén, C.P. Simeón, E. Koumakis, P. Dieude, Y. Allanore, F.J. García-Hernández, G. Espinosa, I. Castellví, J.L. Trapiella, L. Rodriguez, M.A. González-Gay, M.V. Egurbide, L. Sáez, J.L. Callejas-Rubio, J.A. Vargas-Hitos, N. Hunzelmann, G. Riemekasten, T. Witte, J.H. Distler, A. Kreuter, C. Lunardi, A. Santaniello, F.K. Tan, P.G. Shiels, A.L. Herrick, J. Worthington, M.C. Vonk, B.P. Koeleman, T.R. Radstake, M.D. Mayes, J. Martin, A. The Spanish Scleroderma Group
E. Ochoa, J.-E. Martin, S. Assasi, L. Beretta, P. Carreira, A. Guillén, C.P. Simeón, E. Koumakis, P. Dieude, Y. Allanore, F.J. García-Hernández, G. Espinosa, I. Castellví, J.L. Trapiella, L. Rodriguez, M.A. González-Gay, M.V. Egurbide, L. Sáez, J.L. Callejas-Rubio, J.A. Vargas-Hitos, N. Hunzelmann, G. Riemekasten, T. Witte, J.H. Distler, A. Kreuter, C. Lunardi, A. Santaniello, F.K. Tan, P.G. Shiels, A.L. Herrick, J. Worthington, M.C. Vonk, B.P. Koeleman, T.R. Radstake, M.D. Mayes, J. Martin, A. The Spanish Scleroderma Group
CER8310
2015,33,4,Suppl.91
Pg. 0036-0039
Free to view
Increased messenger RNA levels of the mesenchymal cadherin-11 in the peripheral blood of systemic sclerosis patients correlate with diffuse skin involvement
P.F. Christopoulos, V.-K. Bournia, S. Panopoulos, A. Vaiopoulos, M. Koutsilieris, P.P. Sfikakis
P.F. Christopoulos, V.-K. Bournia, S. Panopoulos, A. Vaiopoulos, M. Koutsilieris, P.P. Sfikakis
CER7876
2015,33,4,Suppl.91
Pg. 0040-0046
Free to view
A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines
J. Reed, J.E. Pope
J. Reed, J.E. Pope
CER8055
2015,33,4,Suppl.91
Pg. 0047-0054
Free to view
An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database
M. Brand, R. Hollaender, D. Rosenberg, M. Scott, E. Hunsche, A. Tyndall, V. Denaro, P. Carreira, C. Varju, B. Gabrielli, S. Zingarelli, P. Caramaschi, K. Simic-Pasalic, U. Müller Ladner, M. Vasile, C. Mihai, E. Rosato, A. Vacca, T. Zenone, W.A. Mohamed, C. Ancuta, G. Zampogna, S. Rednic, N. Jabaar, L. Belloli, M.R. Pozzi, R. Foti, U.A. Walker, A. Eustar co-Investigators
M. Brand, R. Hollaender, D. Rosenberg, M. Scott, E. Hunsche, A. Tyndall, V. Denaro, P. Carreira, C. Varju, B. Gabrielli, S. Zingarelli, P. Caramaschi, K. Simic-Pasalic, U. Müller Ladner, M. Vasile, C. Mihai, E. Rosato, A. Vacca, T. Zenone, W.A. Mohamed, C. Ancuta, G. Zampogna, S. Rednic, N. Jabaar, L. Belloli, M.R. Pozzi, R. Foti, U.A. Walker, A. Eustar co-Investigators
CER8405
2015,33,4,Suppl.91
Pg. 0055-0060
Free to view
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis
R. Gualtierotti, F. Ingegnoli, R. Two, P. Meroni, D. Khanna, A. Study Group Veritas
R. Gualtierotti, F. Ingegnoli, R. Two, P. Meroni, D. Khanna, A. Study Group Veritas
CER8654
2015,33,4,Suppl.91
Pg. 0061-0067
Free to view
A Romanian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
M. Gorga, C. Mihai, A.-M. Soare, R. Dobrota, A.-M. Gherghe, V. Stoica
M. Gorga, C. Mihai, A.-M. Soare, R. Dobrota, A.-M. Gherghe, V. Stoica
CER8517
2015,33,4,Suppl.91
Pg. 0068-0074
Free to view
Disease duration and Medsger’s severity score are associated with significant liver fibrosis in patients with systemic sclerosis
S.-W. Lee, B.K. Kim, J.Y. Park, D.Y. Kim, S.H. Ahn, J.J. Song, Y.-B. Park, S.-K. Lee, K.-H. Han, S.U. Kim
S.-W. Lee, B.K. Kim, J.Y. Park, D.Y. Kim, S.H. Ahn, J.J. Song, Y.-B. Park, S.-K. Lee, K.-H. Han, S.U. Kim
CER8639
2015,33,4,Suppl.91
Pg. 0075-0079
Free to view
Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database
B. Sandmeier, V.K. Jäger, G. Nagy, P.E. Carreira, A. Tzankov, M. Widuchowska, M. Antic, O. Distler, H. Reichert, J.H. Distler, U.A. Walker, T. Hügle
B. Sandmeier, V.K. Jäger, G. Nagy, P.E. Carreira, A. Tzankov, M. Widuchowska, M. Antic, O. Distler, H. Reichert, J.H. Distler, U.A. Walker, T. Hügle
Diagnosis
CER7724
2015,33,4,Suppl.91
Pg. 0080-0086
Free to view
Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis
G. Guarnieri, E. Zanatta, P. Mason, M.C. Scarpa, E. Pigatto, P. Maestrelli, F. Cozzi
G. Guarnieri, E. Zanatta, P. Mason, M.C. Scarpa, E. Pigatto, P. Maestrelli, F. Cozzi
CER7434
2015,33,4,Suppl.91
Pg. 0087-0091
Free to view
Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus
F. Moazedi-Fuerst, S. Kielhauser, K. Brickmann, N. Tripolt, M. Meilinger, A. Lufti, W. Graninger
F. Moazedi-Fuerst, S. Kielhauser, K. Brickmann, N. Tripolt, M. Meilinger, A. Lufti, W. Graninger
CER7957
2015,33,4,Suppl.91
Pg. 0092-0097
Free to view
The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis
Y. Yalcinkaya, O. Pehlivan, A. Omma, N. Alpay-Kanitez, B. Erer, S. Kamali, L. Ocal, M. Inanc
Y. Yalcinkaya, O. Pehlivan, A. Omma, N. Alpay-Kanitez, B. Erer, S. Kamali, L. Ocal, M. Inanc
CER7976
2015,33,4,Suppl.91
Pg. 0098-0105
Free to view
Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis
C. Corallo, L. Paulesu, M. Cutolo, F. Ietta, C. Carotenuto, C. Mannelli, R. Romagnoli, R. Nuti, N. Giordano
C. Corallo, L. Paulesu, M. Cutolo, F. Ietta, C. Carotenuto, C. Mannelli, R. Romagnoli, R. Nuti, N. Giordano
CER7760
2015,33,4,Suppl.91
Pg. 0106-0110
Free to view
Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China
S. Zhang, D. Xu, M. Li, Y. Hou, Q. Wang, Z. Tian, Y. Liu, X. Guo, J. Lai, J. Zhao, C. Hu, N. Song, Q. Sun, F. Zhang, Y. Zhao, X. Zeng
S. Zhang, D. Xu, M. Li, Y. Hou, Q. Wang, Z. Tian, Y. Liu, X. Guo, J. Lai, J. Zhao, C. Hu, N. Song, Q. Sun, F. Zhang, Y. Zhao, X. Zeng
CER8009
2015,33,4,Suppl.91
Pg. 0111-0116
Free to view
Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease
O.A. Moore, S.M. Proudman, N. Goh, T.J. Corte, H. Rouse, O. Hennessy, K. Morrisroe, V. Thakkar, J. Sahhar, J. Roddy, P. Youssef, E. Gabbay, P. Nash, J. Zochling, W. Stevens, M. Nikpour
O.A. Moore, S.M. Proudman, N. Goh, T.J. Corte, H. Rouse, O. Hennessy, K. Morrisroe, V. Thakkar, J. Sahhar, J. Roddy, P. Youssef, E. Gabbay, P. Nash, J. Zochling, W. Stevens, M. Nikpour
CER8163
2015,33,4,Suppl.91
Pg. 0117-0122
Free to view
What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?
Y. Braun-Moscovici, M. Braun, D. Khanna, A. Balbir-Gurman, D.E. Furst
Y. Braun-Moscovici, M. Braun, D. Khanna, A. Balbir-Gurman, D.E. Furst
CER8229
2015,33,4,Suppl.91
Pg. 0123-0126
Free to view
Pilot study to determine whether transient receptor potential melastatin type 8 (TRPM8) antibodies are detected in scleroderma
A.A. Shah, J. Montagne, S.-Y. Oh, F.M. Wigley, L. Casciola-Rosen
A.A. Shah, J. Montagne, S.-Y. Oh, F.M. Wigley, L. Casciola-Rosen
CER8448
2015,33,4,Suppl.91
Pg. 0127-0130
Free to view
Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients
I. Silva, A. Teixeira, J. Oliveira, I. Almeida, R. Almeida, C. Vasconcelos
I. Silva, A. Teixeira, J. Oliveira, I. Almeida, R. Almeida, C. Vasconcelos
CER8458
2015,33,4,Suppl.91
Pg. 0131-0135
Free to view
Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival
M. Wodkowski, M. Hudson, S. Proudman, J. Walker, W. Stevens, M. Nikpour, S. Assassi, M.D. Mayes, M. Wang, M. Baron, M.J. Fritzler, A. The Canadian Scleroderma Research Group, A. The Australian Scleroderma Cohort Study, A. The Genetics Versus Environment In Scleroderma Outcome Study
M. Wodkowski, M. Hudson, S. Proudman, J. Walker, W. Stevens, M. Nikpour, S. Assassi, M.D. Mayes, M. Wang, M. Baron, M.J. Fritzler, A. The Canadian Scleroderma Research Group, A. The Australian Scleroderma Cohort Study, A. The Genetics Versus Environment In Scleroderma Outcome Study
CER8563
2015,33,4,Suppl.91
Pg. 0136-0141
Free to view
Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome
I. Pinal-Fernandez, E. Pallisa-Nuñez, A. Selva-O´callaghan, E. Castella-Fierro, C.P. Simeon-Aznar, V. Fonollosa-Pla, M. Vilardell-Tarres
I. Pinal-Fernandez, E. Pallisa-Nuñez, A. Selva-O´callaghan, E. Castella-Fierro, C.P. Simeon-Aznar, V. Fonollosa-Pla, M. Vilardell-Tarres
CER8574
2015,33,4,Suppl.91
Pg. 0142-0147
Free to view
Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease
M. Rizzi, P. Sarzi-Puttini, A. Airoldi, M. Antivalle, M. Battellino, F. Atzeni
M. Rizzi, P. Sarzi-Puttini, A. Airoldi, M. Antivalle, M. Battellino, F. Atzeni
Treatment
CER8088
2015,33,4,Suppl.91
Pg. 0148-0152
Free to view
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study
E. Romano, S. Bellando-Randone, M. Manetti, C. Bruni, G. Lepri, M. Matucci-Cerinic, S. Guiducci
E. Romano, S. Bellando-Randone, M. Manetti, C. Bruni, G. Lepri, M. Matucci-Cerinic, S. Guiducci
CER8158
2015,33,4,Suppl.91
Pg. 0153-0159
Free to view
Content of non-pharmacological care for systemic sclerosis and educational needs of European health professionals: a EUSHNet survey
L.M. Willems, A.C. Redmond, T.A. Stamm, C. Boström, S. Decuman, A. Tyrrell Kennedy, J. Brozd, S. Roškar, V. Smith, T.P. Vliet Vlieland, C.H. Van Den Ende
L.M. Willems, A.C. Redmond, T.A. Stamm, C. Boström, S. Decuman, A. Tyrrell Kennedy, J. Brozd, S. Roškar, V. Smith, T.P. Vliet Vlieland, C.H. Van Den Ende
CER8677
2015,33,4,Suppl.91
Pg. 0160-0167
Free to view
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab
P. Fraticelli, S. De Vita, N. Franzolini, S. Svegliati, C.A. Scott, C. Tonnini, T. Spadoni, B. Gabrielli, G. Pomponio, G. Moroncini, A. Gabrielli
P. Fraticelli, S. De Vita, N. Franzolini, S. Svegliati, C.A. Scott, C. Tonnini, T. Spadoni, B. Gabrielli, G. Pomponio, G. Moroncini, A. Gabrielli
Case Reports
CER7715
2015,33,4,Suppl.91
Pg. 0168-0170
Free to view
Intravenous immunogobulin therapy for severe gastrointestinal involvement in systemic sclerosis
K.E. Clark, O. Etomi, C.P. Denton, V.H. Ong, C.D. Murray
K.E. Clark, O. Etomi, C.P. Denton, V.H. Ong, C.D. Murray
CER7435
2015,33,4,Suppl.91
Pg. 0171-0174
Free to view
Scleroderma renal crisis as an initial presentation of systemic sclerosis: a case report and review of the literature
K.M. Logee, S. Lakshminarayanan
K.M. Logee, S. Lakshminarayanan
CER8350
2015,33,4,Suppl.91
Pg. 0175-0178
Free to view
Tumoural calcinosis of the spine in the course of systemic sclerosis: report of a new case and review of the literature
D. Sambataro, G. Sambataro, E. Zaccara, W. Maglione, C. Vitali, N. Del Papa
D. Sambataro, G. Sambataro, E. Zaccara, W. Maglione, C. Vitali, N. Del Papa
CER8499
2015,33,4,Suppl.91
Pg. 0179-0181
Free to view
Protective role of interleukin-6 in systemic sclerosis gastrointestinal tract involvement: case report and review of the literature
T.M. Frech, M. Hudson
T.M. Frech, M. Hudson
Review
CER8462
2015,33,4,Suppl.91
Pg. 0182-0189
Free to view
Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients
N. Giordano, A. Montella, C. Corallo, G. Ruocco, C. Chirico, A. Palazzuoli, R. Nuti, G. Pecetti
N. Giordano, A. Montella, C. Corallo, G. Ruocco, C. Chirico, A. Palazzuoli, R. Nuti, G. Pecetti
CER8588
2015,33,4,Suppl.91
Pg. 0190-0194
Free to view
Disease-related malnutrition in systemic sclerosis: evidences and implications
V. Codullo, E. Cereda, G. Crepaldi, S. Cappello, C. Montecucco, R. Caccialanza, R. Caporali
V. Codullo, E. Cereda, G. Crepaldi, S. Cappello, C. Montecucco, R. Caccialanza, R. Caporali
Letters to the Editor
CER8419
2015,33,4,Suppl.91
Pg. 0195
Free to view
Capillaroscopic patterns in systemic sclerosis: do we need a “stable” pattern?
P. Clemente-Coelho
P. Clemente-Coelho
CER8386
2015,33,4,Suppl.91
Pg. 0196
Free to view
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan
M. Sebastiani, A. Manfredi, V. Cestelli, E. Praino, F. Cannarile, D. Giuggioli, M. Colaci, C. Ferri
M. Sebastiani, A. Manfredi, V. Cestelli, E. Praino, F. Cannarile, D. Giuggioli, M. Colaci, C. Ferri
CER8130
2015,33,4,Suppl.91
Pg. 0197-0198
Free to view
The antifibrotic role of hepatocyte growth factor in dermal fibroblasts of systemic sclerosis
H.-L. Cao, T.-T. Dou, J.-Q. Yang, J. Jing, M. Zheng, X.-Y. Man
H.-L. Cao, T.-T. Dou, J.-Q. Yang, J. Jing, M. Zheng, X.-Y. Man